openPR Logo
Press release

Group B Streptococcus (GBS) Market Report Analysis and Research Studies: In-Depth Insights and Key Players- Pfizer Inc, MinervaXApS, Wellstat Vaccines LLC.

11-18-2024 02:44 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Group B Streptococcus (GBS) Market

Group B Streptococcus (GBS) Market

The Group B Streptococcus (GBS) Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/group-b-streptococcus-market

What is the projected growth rate (CAGR) of the Global Group B Streptococcus (GBS) market from 2024 to 2031, and what is the market value expected to change by 2031?

The Group B Streptococcus (GBS) Market is valued at a significant CAGR during the forecast period (2024-2031).

Group B Streptococcus (GBS) is a bacterial pathogen often found in the gastrointestinal and genitourinary tracts, capable of causing severe infections in newborns and immunocompromised individuals. GBS is a leading cause of neonatal sepsis and meningitis. Pregnant women are typically screened and treated with antibiotics to prevent transmission during childbirth. Vaccines targeting GBS are under development to reduce infection risks. The pathogen is also associated with urinary tract infections and wound infections in adults. Early diagnosis and management are crucial to mitigating its impact.

Key Developments:

❁ In December 2022, a Hong Kong study revealed that prenatal screening dramatically reduces infant infections and mortality caused by common bacterial infections, particularly Group B Streptococcus (GBS). Approximately 20% of pregnant women carry GBS, which is typically harmless but poses risks to newborns. The implementation of universal prenatal screening led to a significant decline in infection rates, decreasing from one in 1,000 to 0.2 in 1,000 births. This finding underscores the critical role of prenatal care and early detection in safeguarding infant health and reducing bacterial infection-related complications.

List of the Key Players in the Group B Streptococcus (GBS) Market:

Pfizer Inc, MinervaXApS, Wellstat Vaccines LLC, GlaxoSmithKline, LUMINEX CORPORATION, PATH, USAntibiotics, Novartis, HAL, TAJ LIFE SCIENCES PVT. LTD.

Research Process:

Both primary and secondary data sources have been used in the global Group B Streptococcus (GBS) Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Group B Streptococcus (GBS) Market:

By Infection Type: Bacteremia, Meningitis, Sepsis, Pneumonia, Bone and joint infections, Skin and soft tissue infections, Urinary tract infections.

By Treatment: Antibiotics, Surgery.

By End User: Hospitals, Homecare, Specialty Clinics, Others.

Regional Breakout:

The global Group B Streptococcus (GBS) Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=group-b-streptococcus-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Group B Streptococcus (GBS) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Group B Streptococcus (GBS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Group B Streptococcus (GBS) market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Group B Streptococcus (GBS) market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/group-b-streptococcus-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Group B Streptococcus (GBS) market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Group B Streptococcus (GBS) market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Group B Streptococcus (GBS) market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Group B Streptococcus (GBS) market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Group B Streptococcus (GBS) Market Report Analysis and Research Studies: In-Depth Insights and Key Players- Pfizer Inc, MinervaXApS, Wellstat Vaccines LLC. here

News-ID: 3741586 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Electric Vehicle Market Forecast 2025-2032: Impact of Next-Generation Batteries, Charging Infrastructure, and Automotive OEM Expansion on Market Dynamics | BMW Group, BYD Company Ltd., Daimler AG
United States Electric Vehicle Market Forecast 2025-2032: Impact of Next-Generat …
Global Electric Vehicle Market reached US$599.50 billion in 2024 and is expected to reach US$1,194.54 billion by 2032, growing with a CAGR of 9% during the forecast period 2025-2032. The global electric vehicle market encompasses battery-electric, plug-in hybrid, and fuel cell vehicles. EVs are adopted to reduce carbon emissions, improve fuel efficiency, and meet regulatory mandates. Growth is fueled by technological advances in batteries, charging infrastructure, and government incentives. Consumer preference
Global Lymphedema Market 2025-2033: Advancements in Compression Therapy, Minimally Invasive Procedures, and Wearable Devices Driving Market Growth | Tactile Medical, Bio Compression Systems, Inc., BSN-JOBST
Global Lymphedema Market 2025-2033: Advancements in Compression Therapy, Minimal …
The Global Lymphedema Market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033. The global lymphedema market focuses on therapies and devices to manage this chronic condition caused by lymphatic fluid accumulation. Treatments include compression garments, physical therapy, and surgical interventions. Market growth is driven by rising prevalence, especially post-cancer surgeries.
Lab-Grown Diamonds Market Size, Share, Growth Analysis, and Forecast (2025-2032): Sustainable Alternatives Transforming Jewelry and Industrial Applications | Top Manufacturers are ABD Diamonds, WD Advanced Materials, LLC & Adamas One Corp.
Lab-Grown Diamonds Market Size, Share, Growth Analysis, and Forecast (2025-2032) …
As per DataM Intelligence Experts Research Report Global lab-grown diamonds market reached US$ 25.68 billion in 2024 and is expected to reach US$ 55.45 billion by 2032, growing with a CAGR of 10.10% during the forecast period 2025-2032. The lab-grown diamonds market involves diamonds produced using chemical vapor deposition (CVD) or high-pressure high-temperature (HPHT) methods. These diamonds are visually and chemically similar to mined diamonds but are more sustainable. Market growth
United States CRISPR Market Size, Share, Growth Analysis, and Forecast (2025-2033): Gene Editing Innovations Reshaping Therapeutics, Agriculture, and Biotechnology | Takara Bio Inc., QIAGEN, Eurofins Genomics.
United States CRISPR Market Size, Share, Growth Analysis, and Forecast (2025-203 …
CRISPR market reached US$ 3.93 billion in 2024 and is expected to reach US$ 15.92 billion by 2033, growing at a CAGR of 16.8% during the forecast period 2025-2033. The global CRISPR market focuses on the development and commercialization of gene-editing technologies for therapeutics, agriculture, and research. CRISPR enables precise modification of genetic sequences for disease treatment and crop improvement. Growth is fueled by rising biotechnology investments and research applications. Ethical

All 5 Releases


More Releases for GBS

Guillain-Barre Syndrome (GBS) share, Analysis, Growth, Future Outlook | 2025-203 …
Guillain-Barre syndrome is a rare autoimmune condition that affects approximately 100,000 people worldwide each year, with nearly 1 in 78,000 people diagnosed with GBS annually. It is most commonly found in people between the ages of 30 and 50. This disorder occurs when the immune system mistakenly attacks the peripheral nervous system, leading to muscle weakness, numbness, and, in severe cases, paralysis. Although the exact cause of GBS remains unknown,
Group B Streptococcus GBS Diagnosis Market Industry Trends, Size, and Expansion …
A new Report by CoherentMI Market Reports, titled "Group B Streptococcus GBS Diagnosis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Group B Streptococcus GBS Diagnosis market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The group B streptococcus (GBS) diagnosis market is estimated to be valued at USD 1.58
Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market to Hit USD …
DataIntelo's latest report reveals that the Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market was valued at USD XX billion in 2023 and is projected to grow at a significant CAGR of XX% by 2032. This substantial growth is primarily attributed to the increased global awareness regarding the serious implications of GBS infections. As mentioned in the report, raised consciousness about the severity of GBS infections, particularly among pregnant women
US GBS Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets
The US GBS Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global US GBS market. This report explores all the key factors affecting the growth of the global US GBS market, including
Guillain-Barre Syndrome (GBS) Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Guillain-Barre Syndrome (GBS) Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies
B Streptococcus (GBS) Infection Treatment Market to witness remarkable growth By …
"The new report has been added by qyresearch.com to provide detailed insight into the global B Streptococcus (GBS) Infection Treatment market. The study will help to get a better understanding about the B Streptococcus (GBS) Infection Treatment industry competitors, a channel for the distribution, B Streptococcus (GBS) Infection Treatment growth potential, potentially disruptive trends, B Streptococcus (GBS) Infection Treatment industry product innovations, market size value/volume (regional/country level, B Streptococcus (GBS)